DCT
2:13-cv-06929
Janssen Pharma Inc v. Sandoz Inc
General
Filed
11/14/13
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (03/05/18)
Patent Owner
Operating Company (W)
PACER
2:13-cv-06929
CourtD. New Jersey
Judge | Period | PO Win Rate |
|---|---|---|
03/31/14 - 03/24/20 | 72% |
Magistrate
Mark Falk
Plaintiff
Party
Name | Ratings |
|---|---|
L5 A | |
L4 A | |
L2 B | |
L2 B |
No Parties
Attorney
Name | Ratings |
|---|---|
L5 A | |
L2 B | |
L2 B | |
L2 C | |
L2 C | |
L2 C | |
L2 E | |
L1 B | |
L1 C | |
L1 C | |
L5 A | |
L5 A | |
L4 A | |
L1 C | |
L5 B | |
L5 A | |
L4 D | |
L3 C | |
L3 E | |
L2 B | |
L2 B | |
L1 C | |
L1 C | |
L1 D | |
L4 B | |
L2 D | |
L2 E | |
L1 C | |
L1 C | |
GibbonsLocal | L3 B |
L3 A | |
L3 A | |
L2 B | |
L1 C | |
Robinson MillerLocal | L2 B |
L3 C | |
L2 A |
No Attorneys
Defendant
Party
Name | Ratings |
|---|---|
L5 E | |
L5 E | |
L5 E | |
L5 E | |
L3 D |
No Parties
Attorney
Name | Ratings |
|---|---|
L4 B | |
L3 E | |
L3 E | |
L2 C | |
L2 D | |
L2 E | |
L1 D | |
L4 C | |
L3 E | |
Hill Wallack LLPLocal | L3 E |
L3 E | |
L3 E | |
L3 E | |
L5 C | |
L5 E | |
L3 E | |
L2 E | |
L2 C | |
L3 B | |
L2 A | |
L1 B |
No Attorneys